S-0.1, r. 12.1 - Regulation respecting the drugs that may be prescribed or administered by a midwife

Texte complet
À jour au 1er mars 2021
Ce document a valeur officielle.
chapter S-0.1, r. 12.1
Regulation respecting the drugs that may be prescribed or administered by a midwife
Midwives Act
(chapter S-0.1, s. 9, 1st par.).
1. A midwife may, in the practice of the profession, prescribe or administer the drugs listed in the Schedule.
O.C. 1376-2020, s. 1.
2. Despite section 1, a midwife who has obtained a permit to practise before 1 April 2022 must, to prescribe or administer the drugs listed in the Schedule, have completed the training of not more than 12 hours recognized by the Ordre des sages-femmes du Québec on the prescription and administration of drugs in accordance with this Regulation.
O.C. 1376-2020, s. 2.
3. This Regulation replaces the Regulation respecting drugs that a midwife may prescribe or administer in the practice of midwifery (chapter S-0.1, r. 12).
O.C. 1376-2020, s. 3.
4. (Omitted).
O.C. 1376-2020, s. 4.
SCHEDULE
(ss. 1 and 2)
DRUGS THAT MAY BE PRESCRIBED OR ADMINISTERED BY A MIDWIFE
NOTE: The following classification refers to the classification prepared by the American Hospital Formulary Service.
1. Every drug belonging to the following classification, subject to the restrictions indicated:
Restrictions:
AMOnly for the purposes of breastfeeding.
CHOnly in a hospital centre operated by an institution within the meaning of the Act respecting health services and social services (chapter S-4.2) or the Act respecting health services and social services for Cree Native persons (chapter S-5).
PIOnly as part of first-line treatment or if the prescription or administration of the drug as part of second or thirdline treatment constitutes a prophylactic measure in accordance with the clinical practices in force.
SMay only be prescribed.
TOnly while waiting for medical care where transfer of the clinical responsibility of the mother or child to a physician is necessary.
THERAPEUTIC CLASSESTHERAPEUTIC SUBCLASSESSUB-SUBCLASSES THERAPEUTICRESTRICTIONS
AntihistaminesFirst generation antihistaminesEthanolamine derivatives 
Anti-infective agentsAntibacterial agentsAminoglycosidesPI and T
CephalosporinsPI
MacrolidesPI
PenicillinsPI
SulfonamidesPI
Other antibacterial agentsPI
AntifungalsAzoles 
Polyenes 
AntiviralsNucleoside and nucleotide analogs 
AntiprotozoalsMiscellaneous antiprotozoals 
Urinary anti-infective agents  
Autonomic nervous system (A.N.S.) drugsSympathomimeticsAlpha and beta adrenergic agonistsT
Blood medicationAntianemics  
Cardiovascular drugsVasilodilatorsNitrates and nitritesT
Beta-adrenergic blockers T
Calcium channel blockerDihydropyridinesT except for a drug for treating nipple vasospasm
Central nervous system (C.N.S) drugsAnalgesics and antipyreticsNon-steroidal anti-inflammatories 
Opiate agonistsCH
Opiate partial agonistsCH
Miscellaneous analgesics and antipyretics 
Narcotic antidotes T and CH
AnticonvulsantsMiscellaneous anticonvulsantsT
Anxiolytics, sedatives and hypnoticsBenzodiazepines 
Miscellaneous (C.N.S) drugs T
Diagnostic agentsDiabetes mellitus  
Urine and stool analyses  
Electrolytes-diureticsReplacement agents  
Caloric agents  
Eye, ear nose and throat (E.E.N.T.) preparationsE.E.N.T. anti-infective agentsAntibiotics 
Gastrointestinal drugsAntiemeticsAntihistamines 
Other antiemetics 
Antiulcer agents and antacidsHistamine H2-receptor antagonists 
Prostaglandins 
Gastro-duodenal cytoprotective agentAM
Proton pump inhibitor 
Procinetics AM
Hormones and substitutesCorticosteroids T
Oral contraceptives S
Progestogens  
Local anasthetics   
Ocytocics   
Immunizing agentsPassive immunotherapy agents  
Active immunotherapy agents  
Skin and mucous membranesAnti-infective agentsAntibacterial agents 
Antifungals 
Other local anti-infective agents 
Anti-inflammatories  
Antipruritics and local anesthetics  
Vitamins   
2. Any other drug that is not listed in Schedule I of the Regulation respecting the terms and conditions for the sale of medications (chapter P-10, r. 12).
3. Any combination of drugs in this Schedule, subject to applicable restrictions.
O.C. 1376-2020, Sch.
REFERENCES
O.C. 1376-2020, 2021 G.O. 2, 86